suggested that immuno-repression and anti-PD1 resistance were caused by exosomal circTMEM181 by increasing the expression of CD39, and suppressing the ATP-adenosine signaling pathway by targeting CD39 on macrophages could rescue anti-PD1 therapy resistance in HCC (168). The gene discussed is ENTPD1; the disease is hepatocellular carcinoma.